Cargando…

Immunoinformatics analysis and evaluation of recombinant chimeric triple antigen toxoid (r-HAB) against Staphylococcus aureus toxaemia in mouse model

ABSTRACT: Staphylococcus aureus is a serious pathogen unleashing its virulence through several classes of exotoxins such as hemolysins and enterotoxins. In this study, we designed a novel multi-antigen subunit vaccine which can induce innate, humoral and cellular immune responses. Alpha hemolysin, e...

Descripción completa

Detalles Bibliográficos
Autores principales: Kota, Rohini Krishna, Kolla, Harish Babu, Reddy, Prakash Narayana, Kalagatur, Naveen Kumar, Samudrala, Siva Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490849/
https://www.ncbi.nlm.nih.gov/pubmed/34609523
http://dx.doi.org/10.1007/s00253-021-11609-z
_version_ 1784578610673221632
author Kota, Rohini Krishna
Kolla, Harish Babu
Reddy, Prakash Narayana
Kalagatur, Naveen Kumar
Samudrala, Siva Kumar
author_facet Kota, Rohini Krishna
Kolla, Harish Babu
Reddy, Prakash Narayana
Kalagatur, Naveen Kumar
Samudrala, Siva Kumar
author_sort Kota, Rohini Krishna
collection PubMed
description ABSTRACT: Staphylococcus aureus is a serious pathogen unleashing its virulence through several classes of exotoxins such as hemolysins and enterotoxins. In this study, we designed a novel multi-antigen subunit vaccine which can induce innate, humoral and cellular immune responses. Alpha hemolysin, enterotoxins A and B were selected as protective antigens for combining into a triple antigen chimeric protein (HAB). Immunoinformatics analysis predicted HAB protein as a suitable vaccine candidate for inducing both humoral and cellular immune responses. Tertiary structure of the HAB protein was predicted and validated through computational approaches. Docking studies were performed between the HAB protein and mice TLR2 receptor. Furthermore, we constructed and generated recombinant HAB (r-HAB) protein in E. coli and studied its toxicity, immunogenicity and protective efficacy in a mouse model. Triple antigen chimeric protein (r-HAB) was found to be highly immunogenic in mouse as the anti-r-HAB hyperimmune serum was strongly reactive to all three native exotoxins on Western blot. In vitro toxin neutralization assay using anti-r-HAB antibodies demonstrated > 75% neutralization of toxins on RAW 264.7 cell line. Active immunization with r-HAB toxoid gave ~ 83% protection against 2 × lethal dosage of secreted exotoxins. The protection was mediated by induction of strong antibody responses that neutralized the toxins. Passive immunization with anti-r-HAB antibodies gave ~ 50% protection from lethal challenge. In conclusion, in vitro and in vivo testing of r-HAB found the molecule to be nontoxic, highly immunogenic and induced excellent protection towards native toxins in actively immunized and partial protection to passively immunized mice groups. KEY POINTS: • HAB protein was computationally designed to induce humoral and cellular responses. • r-HAB protein was found to be nontoxic, immunogenic and protective in mouse model. • r-HAB conferred protection against lethal challenge in active and passive immunization.
format Online
Article
Text
id pubmed-8490849
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-84908492021-10-05 Immunoinformatics analysis and evaluation of recombinant chimeric triple antigen toxoid (r-HAB) against Staphylococcus aureus toxaemia in mouse model Kota, Rohini Krishna Kolla, Harish Babu Reddy, Prakash Narayana Kalagatur, Naveen Kumar Samudrala, Siva Kumar Appl Microbiol Biotechnol Biotechnologically Relevant Enzymes and Proteins ABSTRACT: Staphylococcus aureus is a serious pathogen unleashing its virulence through several classes of exotoxins such as hemolysins and enterotoxins. In this study, we designed a novel multi-antigen subunit vaccine which can induce innate, humoral and cellular immune responses. Alpha hemolysin, enterotoxins A and B were selected as protective antigens for combining into a triple antigen chimeric protein (HAB). Immunoinformatics analysis predicted HAB protein as a suitable vaccine candidate for inducing both humoral and cellular immune responses. Tertiary structure of the HAB protein was predicted and validated through computational approaches. Docking studies were performed between the HAB protein and mice TLR2 receptor. Furthermore, we constructed and generated recombinant HAB (r-HAB) protein in E. coli and studied its toxicity, immunogenicity and protective efficacy in a mouse model. Triple antigen chimeric protein (r-HAB) was found to be highly immunogenic in mouse as the anti-r-HAB hyperimmune serum was strongly reactive to all three native exotoxins on Western blot. In vitro toxin neutralization assay using anti-r-HAB antibodies demonstrated > 75% neutralization of toxins on RAW 264.7 cell line. Active immunization with r-HAB toxoid gave ~ 83% protection against 2 × lethal dosage of secreted exotoxins. The protection was mediated by induction of strong antibody responses that neutralized the toxins. Passive immunization with anti-r-HAB antibodies gave ~ 50% protection from lethal challenge. In conclusion, in vitro and in vivo testing of r-HAB found the molecule to be nontoxic, highly immunogenic and induced excellent protection towards native toxins in actively immunized and partial protection to passively immunized mice groups. KEY POINTS: • HAB protein was computationally designed to induce humoral and cellular responses. • r-HAB protein was found to be nontoxic, immunogenic and protective in mouse model. • r-HAB conferred protection against lethal challenge in active and passive immunization. Springer Berlin Heidelberg 2021-10-05 2021 /pmc/articles/PMC8490849/ /pubmed/34609523 http://dx.doi.org/10.1007/s00253-021-11609-z Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Biotechnologically Relevant Enzymes and Proteins
Kota, Rohini Krishna
Kolla, Harish Babu
Reddy, Prakash Narayana
Kalagatur, Naveen Kumar
Samudrala, Siva Kumar
Immunoinformatics analysis and evaluation of recombinant chimeric triple antigen toxoid (r-HAB) against Staphylococcus aureus toxaemia in mouse model
title Immunoinformatics analysis and evaluation of recombinant chimeric triple antigen toxoid (r-HAB) against Staphylococcus aureus toxaemia in mouse model
title_full Immunoinformatics analysis and evaluation of recombinant chimeric triple antigen toxoid (r-HAB) against Staphylococcus aureus toxaemia in mouse model
title_fullStr Immunoinformatics analysis and evaluation of recombinant chimeric triple antigen toxoid (r-HAB) against Staphylococcus aureus toxaemia in mouse model
title_full_unstemmed Immunoinformatics analysis and evaluation of recombinant chimeric triple antigen toxoid (r-HAB) against Staphylococcus aureus toxaemia in mouse model
title_short Immunoinformatics analysis and evaluation of recombinant chimeric triple antigen toxoid (r-HAB) against Staphylococcus aureus toxaemia in mouse model
title_sort immunoinformatics analysis and evaluation of recombinant chimeric triple antigen toxoid (r-hab) against staphylococcus aureus toxaemia in mouse model
topic Biotechnologically Relevant Enzymes and Proteins
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490849/
https://www.ncbi.nlm.nih.gov/pubmed/34609523
http://dx.doi.org/10.1007/s00253-021-11609-z
work_keys_str_mv AT kotarohinikrishna immunoinformaticsanalysisandevaluationofrecombinantchimerictripleantigentoxoidrhabagainststaphylococcusaureustoxaemiainmousemodel
AT kollaharishbabu immunoinformaticsanalysisandevaluationofrecombinantchimerictripleantigentoxoidrhabagainststaphylococcusaureustoxaemiainmousemodel
AT reddyprakashnarayana immunoinformaticsanalysisandevaluationofrecombinantchimerictripleantigentoxoidrhabagainststaphylococcusaureustoxaemiainmousemodel
AT kalagaturnaveenkumar immunoinformaticsanalysisandevaluationofrecombinantchimerictripleantigentoxoidrhabagainststaphylococcusaureustoxaemiainmousemodel
AT samudralasivakumar immunoinformaticsanalysisandevaluationofrecombinantchimerictripleantigentoxoidrhabagainststaphylococcusaureustoxaemiainmousemodel